Related references
Note: Only part of the references are listed.Indoleamine 2,3-dioxygenase is a critical regulator of acute graft-versus-host disease lethality
Lisa K. Jasperson et al.
BLOOD (2008)
Histone deacetylase inhibitors decrease Toll-like receptor-mediated activation of proinflammatory gene expression by impairing transcription factor recruitment
Konrad A. Bode et al.
IMMUNOLOGY (2007)
Deacetylase inhibition promotes the generation and function of regulatory T cells
Ran Tao et al.
NATURE MEDICINE (2007)
Histone deacetylase inhibitors affect dendritic cell differentiation and immunogenicity
Alessio Nencioni et al.
CLINICAL CANCER RESEARCH (2007)
Indoleamine 2,3-dioxygenase and tumor-induced tolerance
David H. Munn et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Lymphopenia-induced proliferation of donor T cells reduces their capacity for causing acute graft-versus-host disease
Yoshinobu Maeda et al.
EXPERIMENTAL HEMATOLOGY (2007)
Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma, (CTCL)
Madeleine Duvic et al.
BLOOD (2007)
Histone deacetylase inhibitors increase virus gene expression but decrease CD8+ cell antiviral function in HTLV-1 infection
Angelina Jane Mosley et al.
BLOOD (2006)
Histone deacetylase inhibitors prevent exocytosis of interleukin-1β-containing secretory lysosomes:: role of microtubules
Sonia Carta et al.
BLOOD (2006)
Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO
Maria L. Belladonna et al.
JOURNAL OF IMMUNOLOGY (2006)
Reduction of graft-versus-host disease by histone deacetylase inhibitor suberonylanilide hydroxamic acid is associated with modulation of inflammatory cytokine milieu and involves inhibition of STAT1
Corinna Leng et al.
EXPERIMENTAL HEMATOLOGY (2006)
Histone hyperacetylation is associated with amelioration of experimental colitis in mice
Rainer Glauben et al.
JOURNAL OF IMMUNOLOGY (2006)
Anticancer activities of histone deacetylase inhibitors
Jessica E. Bolden et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer
WK Kelly et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase
DH Munn et al.
IMMUNITY (2005)
Epigenetic control of MHC-II:: interplay between CIITA and histone-modifying enzymes
E Zika et al.
CURRENT OPINION IN IMMUNOLOGY (2005)
Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells
A Nebbioso et al.
NATURE MEDICINE (2005)
Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway
A Insinga et al.
NATURE MEDICINE (2005)
Pharmacological induction of tolerogenic dendritic cells and regulatory T cells
L Adorini et al.
SEMINARS IN IMMUNOLOGY (2004)
Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect
P Reddy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Development of the dendritic cell system during mouse ontogeny
A Dakic et al.
JOURNAL OF IMMUNOLOGY (2004)
Modulation of renal disease in MRL/lpr mice by suberoylanilide hydroxamic acid
CM Reilly et al.
JOURNAL OF IMMUNOLOGY (2004)
Murine plasmacytoid dendritic cells initiate the immunosuppressive pathway of tryptophan catabolism in response to CD200 receptor engagement
F Fallarino et al.
JOURNAL OF IMMUNOLOGY (2004)
Exploiting tolerance processes in transplantation
H Waldmann et al.
SCIENCE (2004)
The gene related to anergy in lymphocytes, an E3 ubiquitin ligase, is necessary for anergy induction in CD4 T cells
CM Seroogy et al.
JOURNAL OF IMMUNOLOGY (2004)
Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes
DH Munn et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Dendritic cells: Emerging pharmacological targets of immunosuppressive drugs
H Hackstein et al.
NATURE REVIEWS IMMUNOLOGY (2004)
Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib
K Sun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
IDO expression by dendritic cells: Tolerance and tryptophan catabolism
AL Mellor et al.
NATURE REVIEWS IMMUNOLOGY (2004)
Histone deacetylases
PA Marks et al.
CURRENT OPINION IN PHARMACOLOGY (2003)
Chromatin dynamics and locus accessibility in the immune system
R Mostoslavsky et al.
NATURE IMMUNOLOGY (2003)
Rapamycin inhibits IL-4-induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo
H Hackstein et al.
BLOOD (2003)
GRAIL:: An E3 ubiquitin ligase that inhibits cytokine gene transcription is expressed in anergic CD4+ T cells
N Anandasabapathy et al.
IMMUNITY (2003)
Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse
K Sato et al.
IMMUNITY (2003)
Histone deacetylase inhibitors: a new class of immunosuppressors targeting a novel signal pathway essential for CD154 expression
S Skov et al.
BLOOD (2003)
Immunobiology of acute graft-versus-host disease
P Reddy et al.
BLOOD REVIEWS (2003)
Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction
AE Morelli et al.
IMMUNOLOGICAL REVIEWS (2003)
Rapamycin inhibits macropinocytosis and mannose receptor-mediated endocytosis by bone marrow-derived dendritic cells
H Hackstein et al.
BLOOD (2002)
Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses
AL Mellor et al.
JOURNAL OF IMMUNOLOGY (2002)
Decoding the patterns of self and nonself by the innate immune system
R Medzhitov et al.
SCIENCE (2002)
Histone-deacetylase inhibitors: Novel drugs for the treatment of cancer
RW Johnstone
NATURE REVIEWS DRUG DISCOVERY (2002)
RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems
K Kobayashi et al.
NATURE (2002)
The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines
F Leoni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Cooperation between complexes that regulate chromatin structure and transcription
GJ Narlikar et al.
CELL (2002)
Mouse and human dendritic cell subtypes
K Shortman et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Flt3 ligand therapy for recipients of allogeneic bone marrow transplants expands host CD8 alpha(+) dendritic cells and reduces experimental acute graft-versus-host disease
T Teshima et al.
BLOOD (2002)
Histone deacetylases and cancer: Causes and therapies
PA Marks et al.
NATURE REVIEWS CANCER (2001)
Interleukin-18 regulates acute graft-versus-host disease by enhancing Fas-mediated donor T cell apoptosis
P Reddy et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Regulatory T cells induced by 1α,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance
S Gregori et al.
JOURNAL OF IMMUNOLOGY (2001)
Dendritic cells: Specialized and regulated antigen processing machines
I Mellman et al.
CELL (2001)
Dendritic cell modulation by 1α,25 dihydroxyvitamin D3 and its analogs:: A vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo
MD Griffin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Activation of MHC class I, II, and CD40 gene expression by histone deacetylase inhibitors
WJ Magner et al.
JOURNAL OF IMMUNOLOGY (2000)
Induction of interleukin 10-producing, nonproliferating CD4+ T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells
H Jonuleit et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
1 alpha,25-dihydroxyvitamin D-3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation
G Penna et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
